dc.contributor.author | Kumar, K | |
dc.contributor.author | Mathai, A | |
dc.contributor.author | Murthy, SI | |
dc.contributor.author | Jalali, S | |
dc.contributor.author | Sangwan, V | |
dc.contributor.author | Pathangay, A | |
dc.contributor.author | Reddy, Pappuru R | |
dc.date.accessioned | 2013-10-18T12:03:12Z | |
dc.date.available | 2013-10-18T12:03:12Z | |
dc.date.issued | 2013-10-16 | |
dc.identifier.citation | Ocul Immunol Inflamm. 2013 Oct 16. | en |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57739 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/24131076 | |
dc.description.abstract | Abstract Purpose: To study the clinical features and visual outcome of sympathetic ophthalmia in pediatric patients attending a tertiary care center. Methods: Retrospective review of patients ≤16 years with sympathetic ophthalmia seen during the period 2001-2011. Results: During this period, 2511 pediatric patients with open globe injuries and 14 patients with sympathetic ophthalmia were seen. Six patients developed sympathetic ophthalmia during follow-up here. The incidence rate of sympathetic ophthalmia is 0.24% (6/2511, 95% CI:0.05-0.43%). The commonest presenting signs were anterior uveitis and exudative detachment. All patients were treated with systemic steroids, while 7 patients received additional immunosuppressive therapy. Eight patients had a follow-up of more than 6 months. Mean presenting best-corrected visual acuity (1.25 ± 1.03 logMAR) in the sympathizing eye improved significant following treatment (0.42 ± 0.80 logMAR, p = 0.003). Conclusions: The incidence of sympathetic ophthalmia was 0.24%. Appropriate immunosuppression can lead to favorable visual outcomes in the sympathizing eye. | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi | en |
dc.title | Sympathetic Ophthalmia in Pediatric Age Group: Clinical Features and Challenges in Management in a Tertiary Center in Southern India | en |
dc.type | Article | en |
dc.description.department | Department of Psychiatry | |